The outcomes of favipiravir exposure in pregnancy: a case series

PURPOSE: As in vitro and in vivo studies reported antiviral efficacy against RNA viruses, favipiravir, a pyrazinecarboxamide derivative, has become one of the treatment options for COVID-19 in some countries including Turkey. Preclinical studies demonstrated the risk for teratogenicity and embryotox...

Descripción completa

Detalles Bibliográficos
Autores principales: Ertem, Ozge, Guner, Ozge, Incir, Canet, Kalkan, Sule, Gelal, Ayse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Maternal-Fetal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136192/
https://www.ncbi.nlm.nih.gov/pubmed/35622152
http://dx.doi.org/10.1007/s00404-022-06615-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136192/
https://www.ncbi.nlm.nih.gov/pubmed/35622152
http://dx.doi.org/10.1007/s00404-022-06615-z

Ejemplares similares